Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FMR1 intronic transcript 1 (FMR1-IT1) is a long non-coding RNA gene transcribed from an intronic region of the FMR1 locus on Xq27.3. While the protein-coding FMR1 gene is well known for its role in fragile X syndrome and related disorders, FMR1-IT1 represents a non-coding transcript of largely unknown function. Its presence reflects the transcriptional complexity of the FMR1 locus, where multiple RNA products, including non-coding RNAs, may contribute to gene regulation, chromatin structure, or epigenetic state. There is emerging evidence that the region of FMR1 intron 1, overlapping where FMR1-IT1 is transcribed, may be differentially methylated in disease states and contribute to FMR1 gene silencing[1][3]. The lncRNA itself is not currently a drug target, but the epigenetic status of its genomic region serves as a diagnostic tool in fragile X syndrome research and may have regulatory significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FMR1 intronic transcript 1 (FMR1-IT1).